US SEC Filings Daily Market Digest — July 17, 2026

16-07-2026

Sigyn Therapeutics, Inc. filed a Form 15-12G with the SEC on July 16, 2026, to terminate the registration of its Common Stock under Section 12(g) of the Securities Exchange Act of 1934 and suspend its duty to file reports under Sections 13 and 15(d). The company had approximately 120 holders of record as of the certification date, and the filing was signed by CEO James A. Joyce on July 15, 2026.

• · The company is deregistering under Rule 12g-4(a)(1) and Rule 12g-4(a)(2).
• · The filing date is July 16, 2026, and the certification date is July 15, 2026.
• · The company's principal executive offices are located at 2301 Historic Decatur Road, Suite 100, San Diego, California 92106.
• · The Commission File Number is 000-55575.

16-07-2026

AlphaTON Capital Corp filed its annual report (20-F) on July 16, 2026, detailing significant operational and financial risks. The company faces exposure to foreign currency fluctuations (Canadian dollar, Swedish krona), reliance on third-party data centers and cloud infrastructure, and geopolitical/regulatory instability in Canada, Sweden, and the EU/EEA. Additionally, the company holds restricted TON tokens that are illiquid and cannot be sold to raise cash, posing a material liquidity risk and potential balance sheet valuation discrepancies.

• · Restricted TON tokens cannot be sold to raise cash even if in the company's best interest or to meet unanticipated liquidity needs.
• · The company cannot reduce exposure to TON price declines during the vesting period, and declines may result in losses that cannot be mitigated through sale.
• · The illiquidity of TON holdings may cause their balance sheet carrying value to differ materially from actual sale proceeds, even after restrictions lapse, due to market depth and timing.
• · Restricted TON should not be considered a source of near-term liquidity in evaluating financial condition or capital resources.
• · Risks include reliance on local utility infrastructure (electricity availability, pricing, grid stability) for power-intensive GPU operations.
• · Potential export control or sanctions restrictions could delay or restrict deployment of advanced computing hardware internationally.
• · Compliance with local data residency or sovereignty requirements could affect infrastructure architecture or operations.

16-07-2026

Spring Valley Acquisition Corp. III filed its annual report (20-F) for the period ending December 31, 2025, highlighting its status as a development-stage fusion energy company with no commercial revenue and significant risks. The company reported cash and cash equivalents of $169.6 million, but total shareholders' equity was negative at ($86.0 million), driven by an accumulated deficit of $444.7 million. While the company has substantial cash to fund near-term operations, its negative equity and history of losses underscore the high-risk, capital-intensive nature of its fusion technology development.

• · The company is a development-stage entity with no revenue from commercial fusion energy operations and a history of losses.
• · Significant capital requirements for R&D and reliance on financing, grants, and partnerships are highlighted as key risks.
• · The company's technology (MTF) faces scientific, engineering, and technical challenges that may prevent commercial viability.
• · Regulatory risks include changes in laws governing fusion energy, nuclear energy, environmental, and export control frameworks.

16-07-2026

NextEra Energy and Dominion Energy have filed applications seeking regulatory approval for their proposed combination, which is expected to close in the second half of 2027. The deal promises $2.25 billion in shareholder-funded bill credits for customers in Virginia, North Carolina, and South Carolina, and includes commitments to local leadership, job protections, and no merger-related costs passed to customers. However, the transaction faces significant regulatory hurdles and customary closing conditions, and the long-term benefits are subject to integration risks and market uncertainties.

• · The combined company would maintain dual corporate headquarters in Richmond, Virginia, and Juno Beach, Florida, and an operational headquarters in Cayce, South Carolina.
• · Dominion Energy's operating companies will remain locally led, separately regulated and accountable to their state commissions.
• · The transaction has been unanimously approved by the boards of directors of both companies.
• · Regulatory approvals required include the Virginia State Corporation Commission, the North Carolina Utilities Commission, the Public Service Commission of South Carolina, the Federal Energy Regulatory Commission, and the Nuclear Regulatory Commission.
• · The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act must expire or be terminated.
• · NextEra Energy is the largest electric power and energy infrastructure company in North America and a Fortune 200 company.
• · Dominion Energy is one of the nation’s leading developers and operators of regulated offshore wind and solar power and the largest producer of carbon-free electricity in New England.

17-07-2026

BOS Better Online Solutions Ltd. (NASDAQ: BOSC) announced a virtual investor event on July 28, 2026, to discuss strategy, execution, and financial discipline. The event will be led by CEO Eyal Cohen, President Avidan Zelicovsky, and CFO Moshe Zeltzer, with a Q&A session. No financial results or performance metrics were disclosed in this filing.

• · Event date: July 28, 2026, at 10 a.m. ET
• · Event will be available via live stream on LinkedIn and YouTube
• · Replay will be posted on the Company's website under 'Events and Presentations'
• · BOS operates through three divisions: Intelligent Robotics, RFID, and Supply Chain

17-07-2026

MindForge Inc. (formerly U-BX Technology Ltd.) announced that its name change to 'MindForge Inc.' became effective on July 15, 2026, following shareholder approval at the annual general meeting on November 4, 2025. The company's Class A ordinary shares will begin trading on the Nasdaq Capital Market under the new symbol 'MF' on July 20, 2026. The CUSIP number remains unchanged.

• · Shareholders approved the name change by special resolution on November 4, 2025.
• · Directors approved implementation on July 10, 2026; effective July 15, 2026.
• · New trading symbol 'MF' begins on July 20, 2026.
• · CUSIP number for Class A ordinary shares remains unchanged.

17-07-2026

Sanofi announced that the U.S. FDA has approved subcutaneous Sarclisa (Escena) as the first anticancer treatment administered via an on-body injector. This approval marks a significant milestone in drug delivery innovation for multiple myeloma therapy.

• · Sarclisa Escena is the first anticancer treatment approved for use with an on-body injector.
• · The approval was granted by the U.S. FDA in July 2026.
• · The press release was issued on July 10, 2026.

17-07-2026

NovaBridge Biosciences' board approved the 2026 Omnibus Share Incentive Plan (the “2026 Plan”), effective July 13, 2026, authorizing an initial maximum aggregate of 11,960,000 ordinary shares for issuance and providing annual increases each January 1 from 2027 equal to the lesser of (i) 3% of outstanding shares as of the immediately preceding December 31 or (ii) a smaller number as determined by the Board. The plan term is ten years. While this expands the share pool for equity compensation (potential dilution), no immediate grants, recipients, or dilution percentages relative to current outstanding shares were disclosed.

• · The 2026 Plan became effective on July 13, 2026 and will continue in effect for a term of ten years.
• · Beginning January 1, 2027, the maximum aggregate shares authorized for issuance under the 2026 Plan will increase annually by the lesser of (i) 3% of outstanding shares as of the immediately preceding December 31 or (ii) a smaller number determined by the Board.
• · The filing does not disclose any specific grants, grant recipients, exercise prices, vesting schedules, or the Company's current outstanding share count, so immediate dilution impact cannot be calculated from this disclosure.
• · The Form 6-K states the information is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-286954) and Form S-8 (File Nos. 333-239871, 333-256603, 333-265684, 333-279842 and 333-290195).

17-07-2026

AITX announced that its subsidiary RAD has received a four-unit RIO 360 order for deployment with one of the world's most recognizable pop culture brands. The order was disclosed via a press release on July 17, 2026. No financial terms or revenue impact were provided, and the filing is furnished (not filed) under Item 8.01, limiting liability.

• · The customer is described as 'one of the world's most recognizable pop culture brands' but is not named.
• · The filing is furnished under Item 8.01 and is not deemed filed for Section 18 liability purposes.
• · No financial details (order value, revenue impact) were disclosed.

17-07-2026

MakeMyTrip Limited announced on July 17, 2026 that its wholly-owned subsidiary, MakeMyTrip (India) Limited (MMT India), has confidentially filed a draft red herring prospectus with Indian regulators for an initial public offering (IPO) on the BSE and NSE. The IPO will involve a sale of equity shares by MakeMyTrip and its subsidiary ibibo Group Holdings, with MMT India remaining a consolidated subsidiary post-offering. Net proceeds are expected to strengthen MakeMyTrip's cash position and be used for long-term growth, strategic inorganic initiatives, and repurchases of securities. The filing does not include any financial performance data, so no period-over-period comparisons are available.

• · The IPO involves a sale of equity shares by MakeMyTrip and its wholly-owned subsidiary ibibo Group Holdings (Singapore) Pte. Ltd.
• · MMT India will continue to be a consolidated subsidiary of MakeMyTrip after the IPO.
• · Net proceeds will be used for long-term growth, strategic inorganic initiatives, and repurchases of different classes of securities (including convertible securities).
• · MakeMyTrip and MMT India may evaluate alternatives in the medium-term to enable shareholders to enjoy benefits of a security at MMT India level that is fungible and listed across India and US capital markets.
• · The securities have not been and will not be registered under the U.S. Securities Act of 1933.

17-07-2026

Kuva Labs Inc., through its subsidiary Kuva Acquisition Corp., is extending its tender offer to acquire all outstanding shares of Lisata Therapeutics, Inc. The offer price is $4.00 per share in cash plus one contingent value right (CVR) of up to $3.00 per share. As of July 15, 2026, approximately 5,897,848 shares (64.67% of outstanding) had been tendered, and the offer expiration has been extended to July 20, 2026. The merger agreement's outside date has also been extended to July 21, 2026.

• · The tender offer was originally scheduled to expire on July 16, 2026, but has been extended to July 20, 2026.
• · The merger agreement's outside date was extended from July 17, 2026 to July 21, 2026.
• · The offer is a third-party tender offer subject to Rule 14d-1.
• · The filing is an amendment (No. 2) to the initial Schedule TO filed on June 10, 2026.

17-07-2026

Regions Financial Corp reported 2Q 2026 net income available to common shareholders of $549 million and diluted EPS of $0.64 (adjusted net income $583 million; adjusted diluted EPS $0.68). Total revenue was essentially flat YoY ($1,907M in 2Q26 vs $1,905M in 2Q25) and increased 1.8% QoQ; adjusted total revenue rose 2.2% YoY and 4.0% QoQ. Loan balances grew (average loans +2% QoQ; ending loans +1% QoQ) driven by business C&I growth, while allowance for credit losses declined $34 million QoQ to $1,613M and ACL/Loans fell to 1.63%; however ACL/NPLs increased to 241% and net charge-offs, though improving QoQ (0.42% annualized vs 0.54% in 1Q26), remain elevated versus long-run lows. The company completed the acquisition of The Frazer Lanier Company on 7/1/2026 to expand capital markets/municipal finance capabilities.

• · Adjusted net income available to common shareholders was $583 million in 2Q26 vs $539 million in 1Q26 (+8% QoQ).
• · Securities repositioning loss of $40 million reduced reported non-interest income in the quarter.
• · Wealth management income hit a record for the quarter at $150 million (5th record quarter in last 6).
• · Salaries and employee benefits increased to $697 million in 2Q26 (+5.8% QoQ) driven by market value adjustments, incentive compensation, and merit increases.
• · FDIC insurance assessments decreased to $17 million (down 11% QoQ) due to an unsecured debt adjustment tied to debt issuance during the quarter.
• · Regions completed acquisition of The Frazer Lanier Company on July 1, 2026 to expand municipal finance and capital markets capabilities.

17-07-2026

Pony AI Inc. filed a Form 6-K with the SEC on July 17, 2026, announcing the date of a board meeting. The filing is a routine disclosure by the foreign private issuer, signed by Chairman and CEO Dr. Jun Peng, and does not contain any financial results or material business updates.

• · The filing is a Form 6-K under SEC Rule 13a-16 or 15d-16.
• · The company's principal executive offices are located at 1301 Pearl Development Building, 1 Mingzhu 1st Street, Hengli Town, Nansha District, Guangzhou, People's Republic of China, 511458.
• · The registrant files annual reports under Form 20-F.

17-07-2026

On July 16, 2026, Targa Resources Corp. appointed Thomas Mathiasmeier to its Board as a Class II Director (term expiring at the 2027 annual meeting) and named him to the Audit Committee. The company expects to grant a pro‑rated restricted stock award of 477 shares and entered into a standard indemnification agreement; no other compensation amounts or cash figures were disclosed. The filing discloses positive governance additions (experienced energy executive) but is otherwise routine with no related-party relationships or extraordinary payments disclosed.

• · Appointment date: July 16, 2026 (report filed July 17, 2026).
• · Mr. Mathiasmeier designated Class II Director with term expiring at the 2027 annual meeting of stockholders.
• · Mr. Mathiasmeier was appointed as a member of the Board’s Audit Committee.
• · Mr. Mathiasmeier most recently served as President, Global Gas, Power & Emerging Markets at ConocoPhillips and retired in June 2026.
• · Company entered into an Indemnification Agreement requiring indemnification to the fullest extent permitted under Delaware law and advancement of expenses.
• · Filing references prior SEC-filed exhibits for the form of the restricted stock agreement (Exhibit 10.13 to Form 10-K filed February 16, 2018) and the form of indemnification agreement (Exhibit 10.4 to Form S-1/A filed November 8, 2010).

17-07-2026

Jasper Therapeutics, Inc. (NASDAQ: JSPR) announced the acquisition of Kira Pharmaceuticals in an all-stock transaction, concurrently raising $132 million in a PIPE offering. On a fully diluted basis, pre-transaction Jasper equityholders will own approximately 6.68%, Kira equityholders will own approximately 49.86%, and PIPE investors will own approximately 43.46% of the combined company. The combined entity plans to advance a pipeline including KP-104 (a bifunctional complement inhibitor targeting C5 and Factor H) and briquilimab (anti-KIT), with key milestones expected through 2028. However, the transaction significantly dilutes existing Jasper shareholders, and the company faces substantial risks related to clinical development, regulatory approval, and the realization of CVR payments contingent on a priority review voucher.

• · The combined company expects to fund operations through 2H 2028 with the $132M PIPE proceeds.
• · CVR payments of up to $30M are contingent on Jasper obtaining a priority review voucher for briquilimab by end of 2028.
• · Out-license of KP-301 and KP-402 to Mirador Therapeutics includes $12M upfront and potential development/sales milestones.
• · KP-104 has a Phase 2 basket trial with interim data expected Q4 2026 (Stage 1) and Q2 2027 (Stage 2).
• · Briquilimab has Orphan Drug, Fast Track, and Rare Pediatric Disease Designations in SCID.
• · The global complement inhibitor market is estimated at $14B+ (2025A-2032E).

17-07-2026

Freedom Metals Acquisition Corp. completed its initial public offering (IPO) of 27,500,000 units at $10.00 per unit, raising $275,000,000 in gross proceeds, and simultaneously closed a private placement of 825,000 units to the sponsor and underwriters for $8,250,000. The net proceeds were placed in a trust account to fund a future business combination, with the company focusing on targets in the mining and critical minerals industry. As a blank-check company with no operations, it faces risks in identifying and completing a suitable acquisition within the required timeframe.

• · The company is a blank-check (SPAC) incorporated in the Cayman Islands on February 25, 2026, with no operations and no identified business combination target.
• · The underwriters forfeited their over-allotment option on July 9, 2026, resulting in the surrender of 1,375,000 Class B ordinary shares by the Sponsor for no consideration.
• · Transaction costs totaled $17,592,906, including $5,500,000 cash underwriting fees and $11,000,000 deferred underwriting fees.
• · The company has a shareholders' deficit of $8,981,439, reflecting accumulated deficit of $8,982,439.
• · The trust account holds $275,000,000, representing $10.00 per public share, which will be used to fund a business combination or returned to shareholders if no deal is completed.
• · The company intends to focus on targets in the mining and critical minerals industry but may pursue any business.

17-07-2026

Activate Energy Acquisition Corp. (AEAQU) announced the resignation of Director Paul Moore from its Board, effective July 13, 2026. The departure was not related to any disagreement with the company regarding its operations, policies, or practices. The Board thanked Mr. Moore for his service.

• · The resignation was effective immediately on July 13, 2026.
• · The company is a blank check (SPAC) incorporated in the Cayman Islands.
• · Its securities trade on the Nasdaq Global Market under symbols AEAQU (Units), AEAQ (Class A ordinary shares), and AEAQW (Warrants).

17-07-2026

BuzzFeed, Inc. appointed Stanley E. Washington as an independent director and Chair of the Compensation Committee, effective July 16, 2026, while Greg Coleman stepped down from the Board after serving since 2021. Washington brings over 40 years of experience in financial services, fintech, and payments, and will also serve on the Audit and Nominating Committees. The filing contains no financial results or period-over-period comparisons, and no negative or flat performance metrics are disclosed.

• · Washington will serve on the Audit Committee, the Nominating, Corporate Governance, and Corporate Responsibility Committee, and as Chair of the Compensation Committee.
• · Greg Coleman had been a Board member since the closing of the business combination in 2021 and served as Chair of the Compensation Committee.
• · Washington currently serves as President and CEO of Pantheon Global Services Inc., an investment and advisory firm.
• · Washington is a Trustee Emeritus of Morehouse College and holds a B.A. in Marketing from Morehouse College.
• · No arrangements or understandings exist between Washington and any other person regarding his selection as a director, and no related party transactions are disclosed.

17-07-2026

Braemar Hotels & Resorts Inc. completed the sale of three hotel properties (The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel and Spa) for approximately $432.7 million in cash, net of transfer taxes and selling expenses, and repaid approximately $232.8 million on the related mortgage loan. The pro forma financials show a significant non-recurring gain of $158.2 million for the year ended December 31, 2025, but also reflect the removal of these properties' revenues and operating income, leading to a decline in ongoing hotel revenue from $704.0 million to $575.5 million. While the sale strengthens the balance sheet with increased cash and reduced debt, it also reduces the company's asset base and future operating income from the disposed properties.

• · The sale closed on July 14, 2026.
• · The pro forma gain on disposition is preliminary and subject to change.
• · Pro forma net income attributable to common stockholders for the year ended Dec 31, 2025 improved from a loss of $72.7M to income of $96.7M, primarily due to the non-recurring gain.
• · Pro forma net income attributable to common stockholders for the three months ended Mar 31, 2026 declined from $4.9M to $1.2M, reflecting the removal of the properties' operating results.
• · Pro forma total assets decreased by $138.1M (7.5%) from $1.85B to $1.71B.
• · Pro forma indebtedness decreased by $232.2M (21.0%) from $1.11B to $873.9M.
• · Pro forma cash and cash equivalents increased by $188.2M (201.5%) from $93.4M to $281.6M.
• · The disposed properties had combined operating losses (before gain) of $7.6M for the year ended Dec 31, 2025 and $1.9M for the three months ended Mar 31, 2026.

17-07-2026

Stewart Information Services Corporation filed an 8-K on July 17, 2026, to disclose that it has prepared an investor presentation deck (Summer 2026) for use in meetings with investors, analysts, and other third parties starting July 16, 2026. The deck is available on the company's investor relations website. The filing is a routine Regulation FD disclosure and does not contain any financial results or material changes.

• · The investor deck is titled 'Stewart Information Services Corporation Investor Deck – Summer 2026' and is attached as Exhibit 99.1.
• · The company does not undertake any obligation to update the information in the deck.
• · The information is furnished, not filed, under the Exchange Act.

17-07-2026

News Corp filed an 8-K on July 17, 2026, disclosing its ongoing stock repurchase program under which it is authorized to buy back up to $1 billion in aggregate of its Class A and Class B common stock. The filing includes daily transaction disclosures provided to the Australian Securities Exchange (ASX) as required by ASX rules. No financial results or material changes were reported.

• · The repurchase program covers both Class A common stock (ticker NWSA) and Class B common stock (ticker NWS).
• · The company is required to provide daily transaction disclosures to the ASX under ASX rules.
• · Exhibits 99.1 and 99.2 contain the ASX disclosure information for the respective dates.

17-07-2026

Constellation Acquisition Corp I (CSTA) filed an 8-K on July 17, 2026, disclosing that Ian Rodger, CEO of HiTech Minerals Inc. and incoming CEO of US Elemental Inc. (PubCo), participated in a Water Tower Research Fireside Chat on July 16, 2026, discussing the proposed business combination between CSTA, HiTech, and PubCo. The filing includes a transcript of the discussion and forward-looking statements regarding the merger, anticipated Nasdaq listing, and financial projections. No specific financial figures or period-over-period comparisons are provided in this disclosure.

• · The business combination involves CSTA, HiTech, and PubCo (US Elemental Inc.).
• · PubCo is expected to list on Nasdaq after the business combination.
• · The filing includes cautionary notes regarding forward-looking statements and risks.
• · A Registration Statement on Form S-4 is being prepared for the transaction.
• · Shareholders are urged to read the proxy statement/prospectus when available.

17-07-2026

ESS Tech, Inc. amended its at-the-market (ATM) offering program on July 16, 2026, terminating four of its five original sales agents (BMO, Canaccord, Needham, and Stifel) and adding Roth Capital Partners as the sole new agent. Roth also replaces Canaccord as the qualified independent underwriter for the offering. The ATM program remains authorized to sell up to $75 million of common stock, but the change in agents may signal a shift in the company's capital-raising strategy.

• · The Original Sales Agreement was entered into on November 13, 2025.
• · The amendment terminates BMO, Canaccord, Needham, and Stifel as sales agents.
• · Roth Capital Partners replaces Canaccord as the qualified independent underwriter under FINRA Rule 5121.
• · YA II PN, Ltd., an affiliate of Yorkville Ives, is a party to the company's Standby Equity Purchase Agreement and is the lender under a Promissory Note with ESS Tech.
• · Yorkville Ives and Roth may provide future commercial banking, financial advisory, and investment banking services for customary fees.

17-07-2026

Mercator Acquisition Corp., a blank check company, priced its $150 million initial public offering of 15,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. The units will trade on Nasdaq under the symbol 'MRCOU' starting July 9, 2026. The company intends to focus on technology and software infrastructure companies targeting financial services, real estate, and asset management, and is led by Shawn Matthews (Chairman & CEO), Steve Bischoff (CFO), and Shawn Matthews Jr. (President).

• · The company is a blank check company formed to effect a merger or similar business combination.
• · The offering was declared effective by the SEC on July 8, 2026.
• · The company has granted underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments.
• · Only whole warrants are exercisable and will trade separately.

17-07-2026

Frequency Electronics Inc. reported a net loss of $0.9M for fiscal year 2026, a sharp reversal from net income of $23.7M in FY2025, as revenue declined 9.4% to $63.2M. The company's gross margin collapsed from 43.1% to 29.1%, driven by a $3.8M inventory write-off from restructuring and a 14.3% revenue drop at its core FEI-NY segment. While the FEI-Zyfer segment grew 16.5%, the overall operating result swung from a $11.7M profit to a $3.0M loss, and cash and equivalents fell to $2.9M from $6.1M.

• · FEI-NY segment revenue declined 14.3% to $45.7M, while FEI-Zyfer grew 16.5% to $21.7M.
• · Gross margin percentage fell from 43.1% to 29.1% due to a $3.8M inventory write-off from restructuring and a $0.4M goodwill derecognition.
• · Selling and administrative expenses increased 25.3% to $15.4M, while R&D expenses decreased slightly to $6.0M.
• · Cash provided by operations was $1.3M in FY2026, compared to cash used of $1.4M in FY2025.
• · Capital expenditures increased to $2.9M from $1.8M in the prior year.
• · The company did not pay a dividend in FY2026, compared to $9.6M in FY2025.
• · Treasury stock purchases increased to $1.6M from $0.4M in FY2025.
• · Total liabilities decreased to $34.3M from $38.1M, driven by a decline in contract liabilities.
• · The company had a benefit from income taxes of $2.0M in FY2026, compared to $11.5M in FY2025.

17-07-2026

Papaya Growth Opportunity Corp. I filed its 10-Q for the period ended September 30, 2025, reporting a net loss of $369,023 for Q3 2025, wider than the $332,277 loss in Q3 2024. For the nine-month period, the net loss increased to $2,167,107 from $933,491 in the prior year, driven by higher general and administrative expenses. Total assets fell sharply to $1,148,886 from $8,202,935 at year-end 2024, primarily due to a $7.0M reduction in cash held in trust from stock redemptions, while the company's accumulated deficit grew to $25,401,033.

• · The company had no Class B common stock issued or outstanding at September 30, 2025 or December 31, 2024.
• · Deferred underwriting fee payable was reduced to $0 at September 30, 2025 from $15,125,000 at December 31, 2024, a non-cash reduction.
• · Excise tax liability increased slightly to $3,016,788 at September 30, 2025 from $2,946,433 at December 31, 2024.
• · Note payable-related party remained at $4,000,000 at both September 30, 2025 and December 31, 2024.
• · Net cash provided by operating activities was only $3,458 for 9M 2025, compared to net cash used in operating activities of $1,188,114 for 9M 2024.
• · Cash at end of period was $48,854 at September 30, 2025, up from $5,576 at December 31, 2024, but still very low relative to liabilities.
• · Basic and diluted net loss per share for Class A common stock was $(0.04) for Q3 2025 versus $(0.03) for Q3 2024, and $(0.24) for 9M 2025 versus $(0.05) for 9M 2024.

17-07-2026

Director Patel Samir Rashmikant exercised/converted 15,466 Pre-Funded Warrant to purchase ADSs at $16.16 (~$250K). 6 transactions reported in total. Patel Samir Rashmikant holds 98,241 shares after the transaction.

• · Director Patel Samir Rashmikant exercised/converted 1,209 American Depositary Shares representing Ordinary Shares at $8.00 (~$9.67K)
• · Director Patel Samir Rashmikant exercised/converted 15,466 American Depositary Shares representing Ordinary Shares at $0.00 (~$6.19)
• · Director Patel Samir Rashmikant exercised/converted 5,799 American Depositary Shares representing Ordinary Shares at $0.00 (~$2.32)
• · Director Patel Samir Rashmikant exercised/converted 1,209 Pre-Funded Warrant to purchase American Depositary Shares at $32.00 (~$38.7K)
• · Director Patel Samir Rashmikant exercised/converted 15,466 Pre-Funded Warrant to purchase ADSs at $16.16 (~$250K)
• · Director Patel Samir Rashmikant exercised/converted 5,799 Pre-Funded Warrant to purchase ADSs at $16.16 (~$93.7K)

17-07-2026

Autoliv reported Q2 2026 net sales of $2,803M, up 3.3% YoY, with organic sales growth of 1.0% outperforming global LVP decline of 0.3%. Adjusted operating margin improved to 9.6% from 9.3% a year ago, and operating cash flow surged 57% to a record $434M for a second quarter. However, GAAP operating income fell 22% to $192M and diluted EPS dropped 38% to $1.35, driven by $90M in restructuring charges from the Türkiye manufacturing discontinuation. The company reiterated full-year 2026 guidance of around 0% organic sales growth and 10.5-11% adjusted operating margin, but expects Q3 margin to be flat with H1 levels before a significant Q4 improvement.

• · Call-off accuracy improved vs Q2 2025 but declined slightly vs Q1 2026, with volatility remaining above pre-pandemic levels.
• · Raw material price changes had a $21M gross negative impact in Q2; full-year 2026 estimate is ~$110M gross impact.
• · Tariff costs net negative impact was ~$7M in Q2 2026, with ~35bps negative impact on operating margin including dilution.
• · Customer compensation achieved for >80% of tariff costs in Q2.
• · U.S. Supreme Court ruling on IEEPA provided a net positive effect of ~$3M.
• · Full-year 2026 tariff-related dilution on operating margin estimated at ~20bps, similar to 2025.
• · Q3 2026 adjusted operating margin expected to be around H1 2026 level (~9.3%), with significant improvement in Q4.
• · Share repurchases of $300-500M targeted for full-year 2026.
• · Chinese OEMs accounted for 55% of Autoliv's China sales in Q2 2026, up from ~40% a year ago.
• · India organic sales grew 36% in Q2, driven by increased safety content per vehicle.
• · Türkiye closure expected to be complete in H1 2028, with annual pre-tax savings of $40M starting 2027.
• · LVP assumption for full-year 2026 guidance: ~2.5% decline.
• · Geopolitical risks highlighted: hostilities in and around the Persian Gulf may affect supply chains and demand.

17-07-2026

Cadeler A/S announced the successful delivery of its eleventh wind installation vessel, Wind Ace, on schedule and within budget. The vessel, built at COSCO Shipping Offshore in China, will be deployed on ScottishPower Renewables' 960 MW East Anglia TWO offshore wind farm starting in 2027. This delivery strengthens Cadeler's fleet to eleven vessels, with a third A-class vessel, Wind Apex, expected in H1 2027.

• · Wind Ace is the second of three A-class newbuilds; the third, Wind Apex, is scheduled for delivery in H1 2027.
• · The vessel achieved over 3.5 million working hours without any lost time accidents during construction.
• · East Anglia TWO is a 960 MW offshore wind farm in the North Sea, expected to power nearly one million homes.
• · Offshore works for East Anglia TWO are scheduled to commence in 2027, with Wind Ace supporting alongside an O-class vessel.

17-07-2026

Tribeca Strategic Acquisition Corp. announced that, effective July 20, 2026, holders of its units may elect to separately trade the Class A ordinary shares and rights included in the units. The separated shares and rights will trade on Nasdaq under symbols 'BID' and 'BIDWR', respectively, while units not separated will continue to trade under 'BIDWU'. The company is a blank check SPAC focused on software, technology, AI, digital assets, and clean energy sectors.

• · Separate trading of Class A ordinary shares and rights begins July 20, 2026.
• · Transfer agent for unit separation is Efficiency, INC.
• · Company is an emerging growth company as defined under SEC rules.
• · SPAC intends to target high-growth sectors including software, technology, artificial intelligence, digital assets, and clean energy.

17-07-2026

Director Li Yanhong Robin had withheld for taxes 830 American depositary share at $49.91 (~$41.4K). Li Yanhong Robin holds 51,282 shares after the transaction.

• · Director Li Yanhong Robin exercised/converted 3,000 American depositary share
• · Director Li Yanhong Robin had withheld for taxes 830 American depositary share at $49.91 (~$41.4K)
• · Director Li Yanhong Robin exercised/converted 30,000 Restricted Share Units

17-07-2026

Director SUMITOMO MITSUI FINANCIAL GROUP, INC. bought 5,906,542 Common Stock at $53.96 (~$319M). SUMITOMO MITSUI FINANCIAL GROUP, INC. holds 8,566,379 shares after the transaction.

• · Director SUMITOMO MITSUI FINANCIAL GROUP, INC. bought 5,906,542 Common Stock at $53.96 (~$319M)

17-07-2026

Four Leaf Acquisition Corp terminated its business combination agreement with Guangzhou Xiaoyu DiDa Technology Co., Ltd. (XYDD) on July 15, 2026, due to a halt in regulatory review under PRC law, in order to pursue a new business combination with Data443 Risk Mitigation, Inc. As compensation for the termination, Data443 issued a $2,000,000 promissory note to XYDD, payable in two installments after deal close, with potential conversion into PubCo shares at a discount. The company is not obligated to pay any termination fee.

• · The XYDD Business Combination Agreement was originally entered into on December 19, 2024.
• · The Compensation Agreement between Data443 and XYDD was entered into on June 25, 2026.
• · Data443 may repay the loan in full at any time before 12 months after deal close.
• · Any portion of the loan that cannot be converted due to the floor or cap remains payable in cash on demand.
• · Disputes under the Compensation Agreement are to be resolved by arbitration administered by the Singapore International Arbitration Centre.

17-07-2026

BHP Group reported mixed FY26 results with total copper production declining 3% to 1,953 kt and iron ore production up 1% to a record 265 Mt. While copper prices surged 35% to US$5.74/lb and steelmaking coal prices rose 8%, the company recorded a ~US$2.3B impairment on the Jansen project and expects negative EBITDA of ~US$150M from both WA Nickel and Jansen. Net debt is expected at ~US$9B as of June 30, 2026, and the adjusted effective tax rate is forecast in the lower half of the 36-40% range.

• · Escondida copper production (100% basis) fell 7% to 1,261 kt due to lower concentrator feed grade of 0.90% (FY25: 1.02%), partially offset by record material mined and record concentrator throughput.
• · Spence copper production dropped 19% to 121.3 kt due to complex ore processing challenges and declining stacked feed grade; two projects sanctioned in June 2026 to address this.
• · Copper South Australia production declined 2% to 99.4 kt, but Olympic Dam achieved a 20-year copper production record.
• · Antamina copper production rose 27% to a financial year record of 152 kt, while zinc production fell 11% to 96 kt.
• · WAIO iron ore production was flat at 257 Mt (291 Mt on 100% basis), with record material mined up 6% and South Flank exceeding annual nameplate capacity.
• · Samarco iron ore production surged 25% to 7.8 Mt due to better concentrator performance.
• · BMA steelmaking coal production increased 3% to 18.6 Mt, with highest stripping volumes in five years and raw coal inventory up ~30%.
• · NSW Energy Coal production rose 9% to 16.361 Mt.
• · WA Nickel produced negligible 0.3 kt (vs 30.2 kt in FY25) and cobalt production was nil (vs 450 t in FY25), reflecting the suspension of operations.
• · Gold payable metal production fell 6% to 340,037 oz, but refined gold production rose 22% to 231,025 oz.
• · Silver total production increased 21% to 17,871 koz, driven by Escondida (+33%) and Antamina (+34%).
• · Uranium production rose 16% to 3,647 t.
• · Molybdenum production plunged 58% to 1,251 t, with Antamina down 84%.
• · Lead production dropped 43% to 1,279 t.
• · Net debt expected at ~US$9B as of 30 June 2026.
• · Capital and exploration spend ~US$5B, proceeds from asset sales ~US$700M.
• · Proceeds from Antamina silver streaming transaction ~US$4.3B.
• · H1 FY26 dividend payment ~US$3.7B, dividends to non-controlling interests ~US$1.4B.
• · Samarco dam failure related: ~US$350M hedging proceeds, ~US$900M settlement payments.
• · Jansen project impairment ~US$2.3B (pre and post-tax).
• · Negative EBITDA of ~US$150M each for WA Nickel and Jansen.
• · Higher depreciation ~US$450M vs H1 FY26 due to project capitalisations.
• · Gain on SolGold disposal ~US$100M.
• · RCII funding for Iron ore US$100-150M.
• · Net cash tax paid US$5,400-5,500M.
• · Dividends received from equity-accounted investments ~US$550M.
• · Working capital decrease (higher operating cash flow) US$600-700M.
• · Adjusted effective tax rate expected in lower half of 36-40% range.
• · FY27 copper production guidance: 1,650-1,800 kt (Escondida grade decline).
• · FY27 iron ore production guidance: 260-272 Mt (WAIO 253-264 Mt).
• · FY27 steelmaking coal production guidance: 18.5-20.5 Mt.
• · FY27 Spence copper production guidance: 210-230 kt.
• · FY27 Copper South Australia production guidance: 290-320 kt (impacted by conveyor belt failure and smelter maintenance).
• · FY27 Antamina copper guidance: 120-140 kt; zinc: 35-55 kt.
• · FY27 Samarco iron ore guidance: 7.5-8.0 Mt.
• · Ministers North project approved for ~US$0.9B investment, first ore expected FY29, >30% IRR.
• · Carrapateena underground conveyor belt failure in July 2026 expected to impact production for up to eight weeks.
• · Cerro Colorado submitted EIA to restart operations and extend mine life by 20 years.
• · Faraday definitive agreements signed to develop Arizona copper hub; BHP's stake to increase to ~32.5%.
• · Outstanding copper sales of 429 kt revalued at US$6.07/lb; 434 kt from FY25 subject to finalisation adjustment.

17-07-2026

Tom ap Simon, President of Higher Education and Virtual Learning at Pearson plc, purchased 515.2426 American Depositary Receipts (ADRs) at $11.645 per ADR for a total of $6,000 on July 14, 2026, through the company's U.S. Employee Stock Purchase Plan. This is a routine insider transaction under a pre-established employee benefit plan, not a discretionary open-market purchase. The filing provides no financial results or material corporate developments.

• · The ADR purchase was for the offering period from January 1, 2026 to June 30, 2026.
• · Each ADR represents one ordinary share of 25 pence in Pearson plc.
• · Transaction occurred on the New York Stock Exchange (XNYS).

17-07-2026

Nomura Holdings reported a mixed set of results for the fiscal year ended March 31, 2026. Net revenue grew 14.5% YoY to ¥2,167,713 million, and net income attributable to NHI shareholders rose 6.3% to ¥362,129 million, marking a fifth consecutive year of profit growth. However, the pace of growth slowed sharply from the prior year's 105.4% surge, and several key segments showed weakness: fees from investment banking declined 5.5% YoY, net interest revenue fell 5.7%, and the cost-to-income ratio remained elevated at 83%. The Wealth Management division performed well, with net revenue up 12.5% and income before income taxes rising 22.8%.

• · Total revenue for FY2026 was ¥4,758,486 million, up 0.5% from ¥4,736,743 million in FY2025.
• · Non-interest expenses grew 14.6% YoY to ¥1,627,892 million, outpacing net revenue growth of 14.5%.
• · Income tax expense increased 32.7% YoY to ¥165,439 million.
• · Net income attributable to noncontrolling interests rose 88.0% YoY to ¥12,253 million.
• · Shareholders' equity as a percentage of total assets declined to 5.9% from 6.1% in FY2025.
• · Cash flows from operating activities were negative ¥842,960 million in FY2026, compared to negative ¥678,611 million in FY2025.
• · Cash flows from investing activities were negative ¥1,498,923 million in FY2026, compared to negative ¥848,647 million in FY2025.
• · Cash flows from financing activities were ¥2,095,851 million in FY2026, up from ¥1,679,697 million in FY2025.
• · Cash, cash equivalents, restricted cash and restricted cash equivalents at end of FY2026 were ¥4,318,722 million, down 2.4% from ¥4,425,441 million in FY2025.
• · Wealth Management client assets grew to ¥175.8 trillion as of March 31, 2026, from ¥143.8 trillion a year earlier, driven by market appreciation of ¥27.1 trillion.
• · Net inflows of recurring revenue assets were ¥1,495.1 billion in FY2026, up 8.8% from ¥1,374.0 billion in FY2025.
• · Labor productivity (revenue per employee) improved to ¥75.6 million in FY2026 from ¥69.5 million in FY2025.
• · Ratio of female managers rose to 23.8% in FY2026 from 22.4% in FY2025, still below the 30% target.
• · Ratio of male employees' childcare leave declined to 94.8% in FY2026 from 100.0% in FY2025, below the 100% target.
• · Training expenses per employee fell to ¥113,805 in FY2026 from ¥133,333 in FY2025.
• · Training hours per employee decreased to 14.4 hours in FY2026 from 15.5 hours in FY2025.
• · Dividend per share for Nomura Securities (subsidiary) was ¥51.00 in FY2026, down from ¥57.00 in FY2025.
• · Payout ratio for Nomura Securities was 111.95% in FY2026, down from 127.00% in FY2025 but still above 100%.
• · Total Shareholder Return for Nomura Securities was 236.3% in FY2026, up from 176.7% in FY2025, outperforming the TOPIX Total Return Index of 202.2%.

17-07-2026

Truist Financial Corp reported strong Q2 2026 results with net income available to common shareholders of $1.5 billion and diluted EPS of $1.23, up 37% year-over-year. Total revenue (TE) grew 2.2% sequentially and 5.5% year-over-year, driven by higher fee income. However, net interest margin (NIM-TE) declined 4 basis points both sequentially and year-over-year to 2.98%, and noninterest expense rose 2.4% sequentially and 2.3% year-over-year, partially offsetting revenue gains.

• · Investment banking and trading income surged 71.7% YoY to $352 million, but declined 5.4% sequentially.
• · Wealth management income grew 7.8% YoY to $375 million.
• · Mortgage banking income fell 12.8% sequentially to $116 million.
• · Average commercial construction loans declined 5.0% sequentially.
• · Average indirect auto loans declined 3.6% sequentially.
• · Average consumer loans decreased 0.3% sequentially.
• · Nonperforming loans as a percentage of loans HFI increased 1 basis point sequentially to 0.51%.
• · The effective tax rate rose to 14.4% in Q2 2026 from 12.4% in Q1 2026, but fell from 18.0% in Q2 2025.
• · Average long-term debt increased 9.4% sequentially and 19% YoY.
• · Average short-term borrowings decreased 5.8% sequentially but increased 10% YoY.
• · The average cost of short-term borrowings rose 19 basis points sequentially to 3.97%.
• · The average cost of total deposits was flat sequentially at 1.56% but down 29 bps YoY.
• · The dividend payout ratio was 42% and the total payout ratio was 121% in Q2 2026.
• · Average consolidated LCR was 113% for Q2 2026, above the 100% regulatory minimum.
• · Total nonperforming assets decreased $37 million sequentially to $1.748 billion.
• · Loans 90+ days past due and still accruing (excluding government guaranteed) were 0.04% of loans HFI.

17-07-2026

IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million in cash (plus up to €50 million earnout), expanding its medical laser platform. The target reported €112.2 million revenue and €24.1 million EBITDA (21.5% margin) for FY2025, and the deal is expected to be accretive to gross margin, EBITDA, and adjusted EPS. The transaction is expected to close in Q4 2026, subject to works council consultation and customary conditions.

• · Lumibird Medical is headquartered in France with three major global facilities.
• · The company's brands include Quantel Medical, Ellex, and Optotek Medical.
• · Lumibird Medical's historical financials are prepared under IFRS; a reconciliation to U.S. GAAP is included in the 8-K appendix.
• · The acquisition will be funded with cash on hand.
• · IPG expects the transaction to close during Q4 2026.
• · A conference call is scheduled for July 17, 2026 at 8:00 a.m. ET.

17-07-2026

Fifth Third Bancorp reported Q2 2026 net income available to common shareholders of $763 million ($0.83 diluted EPS), up 496% sequentially from $128 million ($0.15) but down 6% YoY from $591 million ($0.88). Adjusted EPS of $1.02 excludes $0.19 of certain items. Net interest income (FTE) grew 14% sequentially and 48% YoY to $2.220 billion, driven by the full-quarter Comerica contribution, while noninterest income rose 18% sequentially and 41% YoY to $1.059 billion. However, noninterest expense surged 67% YoY to $2.109 billion, and adjusted noninterest expense excluding certain items rose 51% YoY, reflecting integration costs. Net charge-offs improved to 30 bps (lowest since Q2 2023), but the nonperforming asset ratio ticked up to 0.60% from 0.57% in Q1 2026.

• · Fifth Third surpassed $300 billion in total assets and became a Category III institution in Q2 2026.
• · Systems conversion for Comerica integration is scheduled for Labor Day weekend 2026.
• · Year-to-date merger-related charges represent approximately 65% of the expected full-year total.
• · Period-end commercial portfolio loans grew 2% sequentially, led by C&I, but elevated payoffs partially offset growth.
• · Period-end consumer portfolio loans were flat sequentially; home equity and residential mortgage growth offset by declines in indirect secured consumer and solar energy installation loans.
• · Credit card loans declined 1% YoY and sequentially.
• · Solar energy installation loans declined 3% sequentially.
• · Other short-term investments declined 7% sequentially.
• · Adjusted efficiency ratio improved 480 bps sequentially to 57.1%.
• · CET1 capital ratio was 9.93% at Q2 2026, down from 10.58% a year ago.

17-07-2026

TB Alternative Assets Ltd. filed its quarterly 13F-HR for the period ended June 30, 2026, reporting a total portfolio value of approximately $623.05 million across 34 equity holdings. The fund's largest positions include Intel Corp ($81.96M), Marvell Technology ($76.88M), Taiwan Semiconductor ($75.64M), Meta Platforms ($57.48M), and Alphabet Inc ($56.30M). The filing reflects a diversified mix of technology, semiconductor, and consumer internet stocks, with notable holdings in smaller-cap names such as So-Young International, Mogu Inc., and Youlife Group.

• · The fund holds 34 equity positions with a total market value of $623,051,692 as of June 30, 2026.
• · Top 5 holdings by value: Intel Corp ($81.96M), Marvell Technology ($76.88M), Taiwan Semiconductor ($75.64M), Meta Platforms ($57.48M), and Alphabet Inc ($56.30M).
• · Significant positions in smaller-cap Chinese ADRs: So-Young International (3,067,873 shares), Mogu Inc (684,136 shares), and Youlife Group (1,000,000 shares).
• · The fund also holds leveraged ETF positions: ProShares Ultra Gold ($12.49M) and ProShares Ultra Silver New ($4.01M).
• · All holdings are listed as 'DFND' (defined) with no put/call options or convertible positions reported.

17-07-2026

ECARX Holdings Inc. filed a 6-K on July 17, 2026, disclosing that it upsized its 2025 Convertible Senior Notes to $130 million and secured additional institutional capital support. The press release and amendment deed are attached as exhibits, indicating the company is actively raising debt financing.

• · The filing includes an Amendment Deed (Exhibit 10.1) and a Press Release (Exhibit 99.1) titled 'ECARX Upsizes 2025 Convertible Senior Notes to $130 Million, Secures Additional Institutional Capital Support'
• · The company is incorporated in the UK with principal offices in London

17-07-2026

Cartesian Growth Corp II (REEUF) is soliciting shareholder approval at an Extraordinary General Meeting on July 27, 2026, to extend the deadline to complete an initial business combination from the current termination date to an extended date. The company raised $236.9M in its IPO and has not yet consummated a deal. Insiders, holding ~65.1% of shares, will vote in favor, but public shareholders may redeem their shares at the trust value if they choose.

• · The company is a blank check company incorporated on October 13, 2021, as a Cayman Islands exempted company.
• · The IPO was consummated on May 10, 2022.
• · The Sponsor loan of $4.6M may be repaid or converted into sponsor loan warrants at $1.00 per warrant, identical to private placement warrants.
• · If the business combination is not completed, the trust account proceeds will be distributed to holders of Class A ordinary shares, and the sponsor loan will not be repaid from trust funds.
• · The Adjournment Proposal will only be presented if there are insufficient votes to approve the Extension Proposal at the meeting.

17-07-2026

Prudential plc admitted 3,112 new ordinary shares to trading on the London Stock Exchange on 20 May 2026, issued under the Prudential Sharesave Plan 2023. The new shares are fungible with existing shares, bringing the total admitted shares to 2,507,424,714. This is a routine equity issuance related to employee share plans, with no material financial impact.

• · Admission date: 20 May 2026
• · Shares are ordinary shares of 5 pence each (ISIN GB0007099541)
• · Regulated market: London Stock Exchange Main Market

17-07-2026

EVP & Brand President Saxena Monika was awarded 4,300 Common Stock. Saxena Monika holds 4,300 shares after the transaction.

• · EVP & Brand President Saxena Monika was awarded 4,300 Common Stock
• · EVP & Brand President Saxena Monika was awarded 8,948 Non-Qualified Stock Options